We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
-12.27%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$2.84B
AUM Growth
-$565M
Cap. Flow
-$174M
Cap. Flow %
-6.12%
Top 10 Hldgs %
35.15%
Holding
1,979
New
258
Increased
270
Reduced
192
Closed
921

Sector Composition

Rank Sector Weight
1 Financials 5.44%
2 Technology 4.18%
3 Consumer Discretionary 3.34%
4 Industrials 3.15%
5 Healthcare 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAC
676
CALL
DELISTED
Ares Acquisition Corporation
AAC
$386K 0.01%
39,303
MDLZ icon
677
Mondelez International
MDLZ
$82.9B
$385K 0.01%
6,200
-4,530
-42% -$286K
MTB icon
678
CALL
M&T Bank
MTB
$36.3B
$383K 0.01%
2,400
-500
-17% -$84K
CVII
679
CALL
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$381K 0.01%
39,010
CTSH icon
680
CALL
Cognizant
CTSH
$25.2B
$378K 0.01%
+5,600
New +$429K
COLI
681
DELISTED
Colicity Inc. Class A Common Stock
COLI
$378K 0.01%
38,512
VEEV icon
682
Veeva Systems
VEEV
$33.8B
$377K 0.01%
1,903
-673
-26% -$124K
CSLM
683
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$377K 0.01%
38,500
FVIV
684
CALL
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$376K 0.01%
38,443
GTLB icon
685
GitLab
GTLB
$5.75B
$372K 0.01%
+7,000
New +$326K
TBCP
686
CALL
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$371K 0.01%
37,822
POOL icon
687
Pool Corp
POOL
$7.05B
$369K 0.01%
1,050
+437
+71% +$173K
GPC icon
688
Genuine Parts
GPC
$17.9B
$364K 0.01%
2,737
-1,563
-36% -$208K
AFL icon
689
Aflac
AFL
$65.5B
$360K 0.01%
6,500
-2,600
-29% -$153K
CONX
690
CALL
DELISTED
CONX Corp. Class A Common Stock
CONX
$360K 0.01%
36,471
IBB icon
691
iShares Biotechnology ETF
IBB
$9.45B
$359K 0.01%
+3,054
New +$363K
AMP icon
692
Ameriprise Financial
AMP
$47.8B
$357K 0.01%
+1,500
New +$402K
BIIB icon
693
Biogen
BIIB
$30.9B
$357K 0.01%
1,750
+644
+58% +$132K
INSP icon
694
Inspire Medical Systems
INSP
$1.47B
$356K 0.01%
+1,950
New +$389K
COF icon
695
CALL
Capital One
COF
$128B
$355K 0.01%
3,400
-2,000
-37% -$244K
DKNG icon
696
CALL
DraftKings
DKNG
$12.2B
$350K 0.01%
+30,000
New +$422K
GTI
697
CALL
DELISTED
Graphjet Technology
GTI
$350K 0.01%
583
FEXD
698
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$350K 0.01%
35,000
SMG icon
699
ScottsMiracle-Gro
SMG
$4.09B
$348K 0.01%
+4,400
New +$435K
BSX icon
700
Boston Scientific
BSX
$68.4B
$343K 0.01%
9,204
-28,983
-76% -$1.18M

Similar funds

Paloma Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Paloma Partners held 1,979 positions worth $2.84B, down 17% from $3.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Paloma Partners withdrew a net $174M in Q2 2022, closing 921 positions and reducing 192 holdings. Its most notable exit was SPDR Gold Trust, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5.4% of assets, up from 4.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Paloma Partners opened a new position in Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares) worth $8.16M.

  • Paloma Partners's largest Q2 2022 buy was Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares): 2,820,230 shares worth $8.16M.
  • Paloma Partners added most to State Street Financial Select Sector SPDR ETF in Q2 2022, an estimated $9.95M increase.
  • Paloma Partners's biggest Q2 2022 reduction was Abbott, cutting an estimated $5.07M.
  • Paloma Partners fully exited SPDR Gold Trust in Q2 2022, selling an estimated $13.9M.
  • Paloma Partners's ten largest holdings make up 35% of its $2.84B portfolio in Q2 2022.
  • Paloma Partners opened 258 new positions and closed 921 in Q2 2022.
  • Paloma Partners's portfolio value fell 17% quarter-over-quarter to $2.84B.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.